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receptor agonists, 10, 11 which obviously translates into different responsiveness to these drugs. Furthermore, somatic mutations and individual polymorphisms have been linked to differences in tumour size and secretory pattern. 12, 13 It is therefore apparent that wide-range evaluation of gene expression patterns in corticotroph adenomas is needed to understand which features characterise tumoral corticotrophs and underlie the phenotypical diversity and thus, possibly, pave the way for a personalised clinical strategy. The present study evaluated gene expression profiles in a large series of human ACTH-secreting adenomas. We used RNA extracted from formalin-fixed, paraffin-embedded archival samples collected during transsphenoidal surgery, thus overcoming limitations as a result of the rarity of the disorder.
| MATERIAL S AND ME THODS

| Sample collection
Forty formalin-fixed, paraffin-embedded adenomatous samples were retrieved and sections were microdissected under a surgical microscope. Specimens were collected from the centre of the biopsy to minimise RNA degradation as a result of nucleic acid oxidation.
Immunohistochemistry and neuropathological examination confirmed the diagnosis and the absence of normal pituitary tissue on sections. MIB-1 staining was <3%, attesting to typical corticotroph adenoma (grade I). Overall, specimens had been stored 2-15 years.
Clinical data from patient presentation, surgical outcome and follow-up were collected. The entire series comprised 9 men and 31 women, aged 17-69 years, 29 microadenomas (diameter ≤10 mm) and 11 macroadenomas (diameter >10 mm), 6 surgical failures and the remainder surgical remissions. Mean ± SD follow-after surgery up was 140.3 ± 13.6 months (range 2-15 years). The study was approved by the Ethical Committee of the Istituto Auxologico Italiano.
| RNA formalin-fixed, paraffin-embedded sample extraction
Four 20-μm thick sections from each specimen were extracted using Recover All Total Nucleic Acid Isolation Kit (Life Technologies, Carlsbad, CA, USA). Tissue blocks were deparaffinised in xylene, RNA-bound proteins removed by protease, and RNA captured on glass-filters and eluted. Recovery of RNA averaged 1.5-2 μg per sample. To maximise recovery of adequate transcripts and reduce RNA damage through oxydation, slices were cut from the center of the paraffin block.
| RNA quality control
RNA (200 ng) was reverse-transcribed (Superscript-Vilo cDNA synthesis kit; Life Technologies) and amplified by real-time polymerase chain reaction (PCR) for ribosomal protein L13A (RPL13A), 14 using
Taqman probe Hs03043885_g, (Applied Biosystems, Foster City, CA, USA). All 40 samples yielded the expected 81-bp transcript at <30 cycles, attesting to adequate quality RNA. Expression Omnibus (accession number GSE93825).
| Whole genome-DASL HT
| USP8 sequencing
Approximately 100 ng of RNA was reverse-transcribed (Superscript VILO cDNA synthesis kit; Life Technologies) with the oligonucleotide primers: 5′-CTTGACCCAATCACTGGAAC-3′ (forward);
5′-TTACTGTTGGCTTCCTCTTCTC-3′ (reverse) 13 for amplification of USP8 exon 14, the most frequent site of mutations reported so far.
13
Touch-down PCR was performed using GO TAQ DNA polymerase (Promega, Madison, WI, USA) at 64-57°C annealing. PCR products were purified by ExoProStar Illustra enzyme (Ge Healthcare, Chicago, IL, USA) and Sanger sequencing performed using the ABI PRISM Big DYE Terminator V3.1 cycle sequencing kit (Applied Biosystems) on ABI PRISM 3500 analyser.
| Data analysis
Genome Studio software (Illumina) was used to detect genes significantly expressed in all specimens (ie, genes with detection P < 0 
| Differential gene expression analysis
Once clusters had been established on the basis of similarity in gene expression profiles, differential gene expression analysis enabled the identification of genes that are expressed to a greater or lesser extent in each cluster. genes. Of note, the group leading term is the most significant and genes can be included in several terms. 22 The size of nodes reflects statistical significance of terms, whereas the degree of connectivity between terms (ie, edge) is calculated using Kappa statistics. Table S1 ). In detail, the highest enrichment score was annotated to protein biosynthesis, followed by ribosomal function in group 1. The second-ranked cluster revealed significant enrichment in ribosomal function, RNA processing, membrane transport and lumen, ATP metabolic processes and cytoskeleton organisation. Enrichment scores were lower in groups 3 and 4, mainly annotated to vesicle and lumen function, protein transport and localisation. Enrichment in group 5 was the lowest, with lumen and protease the only annotated functions (see Supporting information, Table S1 ).
| Functional annotation and Gene Ontology
cytoscape analysis revealed that significantly expressed genes formed consistent networks related primarily to protein targeting to the endoplasmic reticulum (ER), cellular macromolecule metabolic processes, RNA and polyRNA binding ( Figure 2 ). Other networks were related to cellular transport of the protein to the ER and Golgi system and to membrane activity, such as vesicle forming and coating. Networks related to post-transcriptional regulation of gene expression and the energy derivation by oxidation of organic compounds were also identified. Altogether, functional annotation by both approaches identified major enrichment of pathways related to protein synthesis and intracellular transport. Of note, this analysis identified genes that characterise the expression profile of corticotroph adenomas per se, and not genes uniquely expressed in tumoral corticotrophs.
| Clinical data analysis
Gene expression profiles led to the grouping of patients in 3 separate clusters (ie, A, B and C). Analyses of differences in clinical variables among clusters revealed a higher proportion of F I G U R E 2 cytoscape analysis showing networks formed by principal significant terms. The number of nodes is proportional to the number of the term-forming genes; nodes are colour-coded according to functional annotations and can have more than 1 colour because genes may belong to more than 1 term. TA (Figure 1 ).
| USP8 sequencing
B L E 1 Hormonal and clinical variables in individual patient clusters (c.2155_2157delTCC, p.Ser718del) and 1 patient showed a novel, 15-bp deletion (c.2157_2171delCCCAGATATAACCCA, p.Pro720_ Gln724del). Gene expression profiles in specimens bearing USP8 variants did not group together, except for the 2 specimens with the same missense variant, which clustered next to each other
| Differentially expressed genes
Comparisons of gene profiles from the 3 different clusters allowed identification of over-or under-expressed genes between clusters.
A Volcano plot (Figure 3) shows genes up-regulated with Diff Score ≥13 and genes down-regulated with Diff Score ≤−13 between cluster A vs clusters B and C ( Figure 3A ), cluster B vs clusters A and C ( Figure 3B) , and cluster C vs clusters A and B ( Figure 3C ).
Of 1259 significantly expressed genes, 4 genes were uniquely overexpressed in cluster A, 313 genes were overexpressed only in cluster B and 29 genes overexpressed only in cluster C ( Table S1 ).
The remaining 190 genes did not fall into specific functional annotation groups. Gene expression profiles in 4 patients differed markedly from all others and clustered separately (cluster C). Amongst genes uniquely overexpressed in this cluster (Table 2) Real-time PCR confirmed overexpression of BCAS2 in cluster A, SCG5 in cluster B and IGFBP5 in cluster C (Figure 4 ), in support of the differential expression observed with respect to microarray data.
TA B L E 2 Genes up-regulated in individual clusters
| D ISCUSS I ON
ACTH-secreting pituitary tumours are a rare and poorly understood disease. The studies performed so far in adenomatous specimens have indicated the involvement of individual genes (ie, mutations in
USP8)
3,4 and the variable expression of factors that mediate sensitivity to glucocorticoids, such as HSP90, BRG-1 and HSD11B2.
5,34,35
Furthermore, cellular models derived from rat or dog tumoral corticotrophs called EGF 36 and RGS2, with the latter being of particular interest because it increases during corticotrophin-releasing hormone incubation in murine tumoral corticotrophs). 45 Moreover, we confirmed the results obtained in 12 corticotroph adenomas reporting the expression of several genes (eg, SEZ6L, CALY, CD200, TCF7L2, NISCH, RUNDC3A
and NGFRAP1). 46 We could also confirm increased expression of Four adenomas presented a markedly different gene expression phenotype and clustered separately (cluster C). IGFBP5 was among the genes highly overexpressed in this cluster, which may prove to be of particular interest given its role in both carcinogenesis and normal cell growth. 55 Indeed, IGFBP5 is known to be expressed in the pituitary itself, independently from growth hormone-producing cells, 56 and, furthermore, IGFBP5 expression and protein synthesis was increased in a subset of nonfunctioning pituitary adenomas. 57 Lastly, overexpression of BCAS2 (breast carcinoma amplified sequence 2) and RPS6KA6 (ribosomal protein S6 kinase 6), both associated with the tumour suppressor p53, 27, 28 as well as RBX1 (ringbox 1), a gene linked to cullin-modulated cell cycle progression 58 , was detected in cluster A; p53 itself has been shown to accumulate in a subset of pituitary ACTH-secreting lesions, in particular invasive adenomas. 59 Accordingly, we observed that patients in cluster A presented the highest prevalence of macroadenomas and invasive tumours and both p53 and cullin-RING pathways represent attractive therapeutic targets. 58 A recent study aimed at identifying the genetic signature of invasive macroadenomas reported an increased expression of CCND2 (cyclin 2) and ZNF676 (zinc-finger protein 676) in 3 invasive adenomas compared to non-invasive corticotroph adenomas. 46 Not surprisingly, neither gene was significantly expressed in our series, which comprised 12 invasive adenomas, because our study aim differed and required an unforced approach to gene expression analysis (ie, unsupervised clustering without a priori classification); additional studies into this as well as other group-derived signatures will allow the above results to be extended and confirmed.
In conclusion, the present study describes the gene expression profile of human pituitary ACTH-secreting adenomas and has identified genes associated with distinct expression clusters. Overall, it appears that these tumours present a neuroendocrine cell profile but, at the same time, there are clearly distinct gene expression patterns in individual subgroups. This evidence provides the basis for future studies into the molecular pathophysiology of these adenomas and, possibly, paves the way to target therapy.
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